Published financial brief
4535B
ADICET BIO INC
- As of
- 2024-12-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
3 data notes
- Input provenance requires review.
- A ratio denominator is near zero.
- One or more values are unavailable.
Exact-period record
Fundamentals
5 reported periods
| Metric | FY 20202020-12-31 | FY 20212021-12-31 | FY 20222022-12-31 | FY 20232023-12-31 | FY 20242024-12-31 |
|---|---|---|---|---|---|
| Financial statements | |||||
| RevenueUSD millions | 17.9 | 9.7 | 25 | 0 | 0 |
| Cost of goods soldUSD millions | 50.7 | 69.4 | 95 | 0 | 0 |
| Selling, general and administrative expenseUSD millions | —missing | —missing | —missing | 126.5 | 121.2 |
| Depreciation and amortizationUSD millions | 1.2 | 1.5 | 2.6 | 6.1 | 6.5 |
| Net incomeUSD millions | -36.7 | -62 | -69.8 | -142.7 | -117.1 |
| Operating profit (EBIT)USD millions | -34 | -61.2 | -72.6 | -132.6 | -127.6 |
| Income taxesUSD millions | -2.8 | -0.1 | 0 | 0 | 0 |
| Short-term debtUSD millions | 1.2 | 1.6 | 2.5 | 3.2 | 3.1 |
| Long-term debtUSD millions | 20.4 | 19.4 | 18.5 | 17.7 | 14.1 |
| Cash and equivalentsUSD millions | 94.6 | 277.5 | 257.7 | 159.7 | 176.3 |
| ReceivablesUSD millions | 2.7 | 0.2 | 0.4 | 0 | 0 |
| InventoryUSD millions | 0 | 0 | 0 | 0 | 0 |
| PayablesUSD millions | 1.6 | 3.3 | 4.4 | 2.6 | 4.8 |
| Net property, plant and equipmentUSD millions | 25.9 | 35 | 49 | 44.2 | 36.8 |
| Capital expenditureUSD millions | 1 | 13 | 16.8 | 4.5 | 1.1 |
| Operating cash flowUSD millions | -41.6 | -51.1 | -44.8 | -93.7 | -92.4 |
| Prepaid expensesUSD millions | 2.6 | 4.7 | —missing | —missing | —missing |
| AccrualsUSD millions | 5.7 | 6.7 | 12.8 | 13.4 | 11.4 |
| EBITDAUSD millions | -32.8 | -59.7 | -70 | -126.5 | -121.2 |
| Working capitalUSD millions | 77.9 | 266.1 | 241.3 | 143 | 160.7 |
| Working capital requirementUSD millions | 1.2 | -3 | -4 | -2.6 | -4.8 |
| Total debtUSD millions | 21.6 | 20.9 | 21 | 20.9 | 17.2 |
| Free cash flowUSD millions | -42.5 | -64.1 | -61.5 | -98.2 | -93.5 |
| Unlevered free cash flowUSD millions | -32.6 | -68.4 | -85.8 | -132.3 | -120.1 |
| Returns and ratios | |||||
| ROICratio | -46.2% | -86.2% | -86.4% | -318.9% | -399.8% |
| Pre-tax ROICratio | -49.7% | -86.4% | -86.4% | -318.9% | -399.8% |
| Effective tax rateratio | 7.1% | 0.2% | 0% | 0% | 0% |
| Revenue growthratio | 1,699.3% | -45.7% | 156.8% | -100% | —missing |
| EBIT / Revenueratio | -189.9% | -629.2% | -290.3% | —missing | —missing |
| Revenue / Invested capitalmultiple | 0.26× | 0.14× | 0.3× | 0× | 0× |
| Cogs Over Revenuesratio | 283% | 713.4% | 380% | —missing | —missing |
| Sga Over Revenuesratio | —missing | —missing | —missing | —missing | —missing |
| Da Over Revenuesratio | 6.8% | 15.8% | 10.3% | —missing | —missing |
| Nfa Over Revenuesratio | 144.4% | 359.7% | 196% | —missing | —missing |
| Wcr Over Revenuesratio | 6.6% | -31.3% | -15.9% | —missing | —missing |
| Debt Over Ebitdamultiple | —missing | —missing | —missing | —missing | —missing |
| St Debt Over Cashmultiple | 0.01× | 0.01× | 0.01× | 0.02× | 0.02× |
| Interest Over Ebitdamultiple | —missing | —missing | —missing | —missing | —missing |
| Interest Over Nocf Nicfmultiple | -0× | -0× | -0× | -0× | -0× |
| Nsf Over Wcrmultiple | -79.22× | 90.51× | 64.29× | 59.62× | 35.85× |
Ask this snapshot
Research assistant
4535B · annualSnapshot 57e9a2be
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000